medline.ch Onkologie Urologische Tumoren

	Comparative analysis of genitourinary toxicity following bladder outlet obstruction procedures in patients before versus after radiotherapy for localized prostate cancer: a retrospective cohort study using the TriNetX database. Prostate Cancer Prostatic Dis Titus RS, Su J, Riveros C, Chen A, Shah HN, Satkunasivam R, Omidele O, Gonzalez RR. PMID: 42203958 [PubMed - as supplied by publisher]
	Optimizing the clinical management of prostate cancer in Taiwan: A multidisciplinary consensus. J Formos Med Assoc Shih-Chieh Chueh J, Cha TL, Hsueh FJ, Chen SC, Lin KJ, You BW, Zhao XJ, Yang JF, Li WI, Tsai CW, Hsu CY, Chang CH, Chen F, Said P, McMahon A. PMID: 42203621 [PubMed - as supplied by publisher]
	Reply to Tonghu Liu's Letter to the Editor re: Bacillus Calmette-GuÃ©rin Plus Mitomycin Versus Bacillus Calmette-GuÃ©rin Alone for Bacillus Calmette GuÃ©rin-naÃ¯ve Non-Muscle-Invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.01.009. Eur Urol Focus Hayne D, Zhang AY, Thomas H, Redfern AD, Davis ID, Stockler MR. PMID: 42203610 [PubMed - as supplied by publisher]
	Re: Hayne D, Zhang AY, Thomas H, et al. Bacillus Calmette-GuÃ©rin Plus Mitomycin Versus Bacillus Calmette-GuÃ©rin Alone for Bacillus Calmette-GuÃ©rin-naÃ¯ve Non-muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.01.009. Eur Urol Focus Liu T, Zhu C, Yan Z. PMID: 42203609 [PubMed - as supplied by publisher]
	Real-world Patterns and Trends of Intravesical Chemotherapy for Non-muscle Invasive Bladder Cancer: Insights from a Large Prospective German Cohort. Anticancer Res Klatte T, Hofbauer SL, Ebert J, Ecke TH. PMID: 42203344 [PubMed - indexed for MEDLINE]
	Three-factor Clinical Score for First-line Nivolumab Plus Ipilimumab in Metastatic Renal Cell Carcinoma. Anticancer Res Yanishi M, Nakamoto T, Yoshida T, Mishima T, Kinoshita H. PMID: 42203341 [PubMed - indexed for MEDLINE]
	Development of a Prognostic Model for Patients Aged â‰¤65 Years With Metastatic Renal Cell Carcinoma. Anticancer Res Oishi Y, Matsushita Y, Watanabe S, Watanabe K, Watanabe H, Tamura K, Motoyama D, Yanagisawa T, Mori K, Sugiyama S, Bekku K, Toyoda S, Nukaya T, Maenosono R, Komura K, Araki M, Fujita K, Takahara K, Azuma H, Inamoto T, JK-FOOT STUDY GROUP. PMID: 42203336 [PubMed - indexed for MEDLINE]
	Basaloid Urothelial Carcinoma Presenting With Paraneoplastic Hypercalcemia and Leukocytosis: A Case Report and Literature Review. Anticancer Res Sabbadini P, Paganoni E, Galeasso L, Depetris I, DI Maio M, Filippi R. PMID: 42203335 [PubMed - indexed for MEDLINE]
	Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate Cancer. Anticancer Res Yamada Y, Matsumoto M, Ikehara M, Tsujino T, Sato K, Saito S, Yoshikawa Y, Maenosono R, Yamamoto S, Arai T, Sato H, Higuchi K, Takei A, Kanesaka M, Ando K, Pae S, Kanaoka S, Takeshita N, Yoneda K, Hino D, Tamura T, Sazuka T, Imamura Y, Mikami K, Nakamura K, Fukasawa S, Kurozumi A, Naya Y, Nagata M, Komaru A, Tobe T, Suzuki N, Azuma H, Sakamoto S. PMID: 42203332 [PubMed - indexed for MEDLINE]
	Predictive Role of PSA Kinetics in Oncological Outcomes of Metastatic Castration-sensitive Prostate Cancer. Anticancer Res Yamamoto Y, Matsumura N, Fujimoto S, Morita T, Uchimoto T, Fukuokaya W, Saruta M, Sugiyama S, Tamura K, Azuma H, Kimura T, Takahara K, Komura K, Inamoto T, Fujita K. PMID: 42203328 [PubMed - indexed for MEDLINE]
	Exploration of the Challenges in the Management of Prostate Cancer in East Africa. Clin Genitourin Cancer Adeniyi IA, Shehu UU, Ikuomola EO, Mohammed SMA, Archibong V, Usman IM. PMID: 42202495 [PubMed - as supplied by publisher]
	Micro-ultrasound as an alternative to MRI in prostate cancer biopsy: Correlation with prostatectomy findings. Urol Oncol Furlano K, Plage H, Hertzsprung N, Jeutner J, Mala K, Gerdes B, Weinberger S, Ralla B, Schlomm T, Reimann M. PMID: 42202428 [PubMed - as supplied by publisher]
	Multimodal Prediction of Renal Tumor Malignancy From Radiology Reports and Structured Electronic Health Records: Retrospective Cohort Study. JMIR Med Inform Fan Z, Liang R, Sun C, Pan J, Terry R, Xu J. PMID: 42202288 [PubMed - indexed for MEDLINE]
	Response to 'Impact of control selection strategies on GWAS results: a study of prostate cancer in the UK Biobank'. Brief Bioinform Law PJ, Went M, Houlston RS. PMID: 42202284 [PubMed - in process]
	Mechanisms and therapeutic implications of metabolic heterogeneity and histone lactylation in clear cell renal cell carcinoma. Discov Oncol Ma J, Qiang Z, Xie W, Jiao L, Wang Y, Mi L, Yang Z, Chen G. PMID: 42201572 [PubMed - as supplied by publisher]
	3D surgical navigation contributes to renal function preservation during robot-assisted partial nephrectomy. J Robot Surg Park MU, Suh J, Kim JK, Song C. PMID: 42201407 [PubMed - indexed for MEDLINE]
	PROQURE-I: a phase I study adding concurrent [(177)Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer. Eur J Nucl Med Mol Imaging Zuur LG, Hoogenkamp DS, van der Sar ECA, van Asten D, Lam MGEH, van der Voort-van Zyp JRN, van Leeuwen PJ, de Wit-van der Veen BJ, de Vries-Huizing DMV, Hendrikx JJMA, Braat AJAT, Vogel WV. PMID: 42201380 [PubMed - as supplied by publisher]
	Beyond PSA-Can Systemic Inflammatory Indices Improve Prostate Cancer Detection? Med Sci (Basel) Iv, Shurrab A, Puia D, Iv, Corlade-Andrei M, Stoican N, Pricop C. PMID: 42201035 [PubMed - indexed for MEDLINE]
	Synchronous Prostate Adenocarcinoma and Bladder Carcinoma In Situ Detected During Evaluation of Incidental PSA Elevation: A Case Report Illustrating Multimodal Diagnostic Correlation and Long-Term Follow-Up. Reports (MDPI) Borta SM, Cri, Miklos I, Zdremtan D, Coman RA. PMID: 42200870 [PubMed]
	Rectal mucinous adenocarcinoma mimicking prostatic urothelial carcinoma: A diagnostic and therapeutic challenge. Urol Case Rep Homeniuk A, Ge R. PMID: 42200115 [PubMed]

Artikel 1 - 20 / 178577

Seite 1 von 8929

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung